Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03623854
Title Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Age Groups: senior | adult | child
Covered Countries USA

No variant requirements are available.